down arrow

Vista Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
12.07
0.57 (4.96%)
BSENSE

Apr 11, 12:05 PM

BSE+NSE Vol: 1.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Vista Pharmaceuticals Ltd stock-summary
stock-summary
Vista Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
Company Coordinates stock-summary
Company Details
Plot No 10to14 16to20 APIIC, Industrial Estate Chotyal Nalgonda Telangana : 0
stock-summary
Tel: 91-09291015956
stock-summary
admin.hyd@vistapharmaceuticals.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 7.76 Cr
Number of Shares
3.88 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
06-Dec-2023
3.88
7.76
200000
2
Conversion of Warrants
28-Nov-2023
3.86
7.72
640000
2
Conversion of Warrants
16-Oct-2023
3.8
7.60
466667
0
Conversion of Warrants
24-Apr-2023
3.75
7.50
720035
2
Conversion of Warrants
03-Aug-2020
3.68
7.36
4285714
2
Preferential basis
13-Jul-2020
3.25
6.50
1071428
2
Preferential basis
07-Jul-2020
3.14
6.29
1071428
2
Preferential basis
06-Feb-2019
3.04
6.07
190574
2
Conversion of Warrants
06-Feb-2019
3.04
6.07
190574
2
Conversion of Warrants
24-Jan-2019
3.02
6.03
189852
2
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (0.02%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Vista Pharmaceuticals Inc (10.69%)

Highest Public shareholder

Murali Meraga (14.62%)

Individual Investors Holdings

34.0%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Dhananjaya Alli
Chairman & Wholetime Director
0
G Narendra
Non-Exec. & Independent Dir.
0
M H Rao
Non-Exec & Non-Independent Dir
0
Stanley Prabhakar Reddy
Non-Exec & Non-Independent Dir
0
Umesh V Banakar
Non-Exec. & Independent Dir.
0
Chakravarthula Divya Bhavani
Non-Exec. & Independent Dir.
0
Umakanth Katta
Director
0
Divakar Reddy Yerrabommanahalli
Director
0
Murali Meraga
Managing Director
0
Pavan Sathvik Gilaka
Whole Time Director (Operatio
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Matls.Consumed
26.8107
0%
 
100
Raw Matls.Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products
31.07
100.00%
 
100
Pharmaceutical Products
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-1 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 45 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.22

stock-summary
Return on Equity

-8.58%

stock-summary
Price to Book

1.25